| Ident. | Authors (with country if any) | Title |
|---|
| 000190 (2021) |
Susan Gould [Royaume-Uni] ; Susan L. Norris [États-Unis] | Contested effects and chaotic policies: the 2020 story of (hydroxy) chloroquine for treating COVID-19. |
| 000345 (2021) |
Romain Lutaud [France] ; Dimiti Scronias [France] ; Jeremy Ward [France] ; Pierre Verger [France] | The hydroxychloroquine debate: a therapeutic dilemma for general practitioners. |
| 000365 (2021) |
Jean Gaudart [France] ; Jordi Landier [France] ; Laetitia Huiart [Luxembourg (pays)] ; Eva Legendre [France] ; Laurent Lehot [France] ; Marc Karim Bendiane [France] ; Laurent Chiche [France] ; Aliette Petitjean [France] ; Emilie Mosnier [France] ; Fati Kirakoya-Samadoulougou [Belgique] ; Jacques Demongeot [France] ; Renaud Piarroux [France] ; Stanislas Rebaudet [France] | Factors associated with the spatial heterogeneity of the first wave of COVID-19 in France: a nationwide geo-epidemiological study. |
| 000668 (2021) |
Matthieu Million [France] ; Audrey Giraud-Gatineau [France] ; Jean-Christophe Lagier [France] ; Philippe Parola [France] ; Philippe Gautret [France] ; Didier Raoult [France] | Reply to Lebeaux D, Revest M. No evidence of clinical benefits of early treatment of COVID-19 patients with hydroxychloroquine and azithromycin. |
| 000791 (2021) |
Etienne Meriglier [France] ; Claire Rivoisy [France] ; Mojgan Hessamfar [France] ; Noelle Bernard [France] ; Ines Aureau [France] ; Joelle Lapoirie [France] ; Anne Contis [France] ; Frédéric Sacher [France] ; Benjamin Sacristan [France] ; Marin Lahouati [France] ; Stéphane Pedeboscq [France] ; Marie-Anne Vandenhende [France] ; Stéphane Bouchet [France] ; Fabrice Bonnet [France] | Safety of hydroxychloroquine and darunavir or lopinavir in COVID-19 infection. |
| 000A46 (2020) |
Alexandre Duvignaud [France] ; Edouard Lhomme [France] ; Thierry Pistone [France] ; Racha Onaisi [France] ; Rémi Sitta [France] ; Valérie Journot [France] ; Duc Nguyen [France] ; Nathan Peiffer-Smadja [France, Royaume-Uni] ; Antoine Crémer [France] ; Stéphane Bouchet [France] ; Thomas Darnaud [France] ; Delphine Poitrenaud [France] ; Lionel Piroth [France] ; Christine Binquet [France] ; Jean-François Michel [Luxembourg (pays)] ; Benjamin Lefèvre [France] ; David Lebeaux [France] ; Josselin Lebel [France] ; Julie Dupouy [France] ; Caroline Roussillon [France] ; Anne Gimbert [France] ; Linda Wittkop [France] ; Rodolphe Thiébaut [France] ; Joanna Orne-Gliemann [France] ; Jean-Philippe Joseph [France] ; Laura Richert [France] ; Xavier Anglaret [France] ; Denis Malvy [France] | Home Treatment of Older People with Symptomatic SARS-CoV-2 Infection (COVID-19): A structured Summary of a Study Protocol for a Multi-Arm Multi-Stage (MAMS) Randomized Trial to Evaluate the Efficacy and Tolerability of Several Experimental Treatments to Reduce the Risk of Hospitalisation or Death in outpatients aged 65 years or older (COVERAGE trial). |
| 000B44 (2020) |
Jean Joel Bigna [France] ; Joseph Kamtchum-Tatuene [Canada] ; Jean Jacques Noubiap [Australie] | Claims about the safety and efficacy of early treatment of COVID-19 with hydroxychloroquine and azithromycin must be supported by real evidence. |
| 000C31 (2020) |
Peng Liu [France] ; Liwei Zhao [France] ; Gladys Ferrere [France] ; Carolina Alves-Costa-Silva [France] ; Pierre Ly [France] ; Qi Wu [France] ; Ai-Ling Tian [France] ; Lisa Derosa [France] ; Laurence Zitvogel [France] ; Oliver Kepp [France] ; Guido Kroemer [France, République populaire de Chine, Suède] | Combination treatments with hydroxychloroquine and azithromycin are compatible with the therapeutic induction of anticancer immune responses. |
| 000C87 (2020) |
Aimé Bonny [Cameroun] ; Mohammed A. Talle [Nigeria] ; Marcus Ngantcha [Cameroun] ; Muzahir H. Tayebjee [Royaume-Uni] | Conflicting evidence on the efficacy of hydroxychloroquine and azithromycin as the early treatment of COVID-19. Comment on "Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, France". |
| 000D26 (2020) |
Nicolas Keller [France] ; François Chantrel [France] ; Thierry Krummel [France] ; Dorothée Bazin-Kara [France] ; Anne Laure Faller [France] ; Clotilde Muller [France] ; Thimothée Nussbaumer [France] ; Manfred Ismer [France] ; Abdellatif Benmoussa [France] ; Mohamed Brahim-Bouna [France] ; Stéphanie Beier [France] ; Peggy Perrin [France] ; Theirry Hannedouche [France] | Impact of first-wave COronaVIrus disease 2019 infection in patients on haemoDIALysis in Alsace: the observational COVIDIAL study. |
| 000D71 (2020) |
Sophie Caillard [France] ; Dany Anglicheau [France] ; Marie Matignon [France] ; Antoine Durrbach [France] ; Clarisse Greze [France] ; Luc Frimat [France] ; Olivier Thaunat [France] ; Tristan Legris [France] ; Valerie Moal [France] ; Pierre Francois Westeel [France] ; Nassim Kamar [France] ; Philippe Gatault [France] ; Renaud Snanoudj [France] ; Antoine Sicard [France] ; Dominique Bertrand [France] ; Charlotte Colosio [France] ; Lionel Couzi [France] ; Jonathan M. Chemouny [France] ; Christophe Masset [France] ; Gilles Blancho [France] ; Jamal Bamoulid [France] ; Agnes Duveau [France] ; Nicolas Bouvier [France] ; Nathalie Chavarot [France] ; Philippe Grimbert [France] ; Bruno Moulin [France] ; Yannick Le Meur [France] ; Marc Hazzan [France] | An initial report from the French SOT COVID Registry suggests high mortality due to COVID-19 in recipients of kidney transplants. |
| 000D91 (2020) |
Philippe Giaime [France] ; Maxime Guenoun [France] ; Nathalie Pedinielli [France] ; Hervé Narbonne [France] ; Jean-Philippe Bergounioux [France] ; Caroline Solas [France] ; Romain Guilhaumou [France] ; Jérôme Sampol [France] ; Jacques Ollier [France] ; Hélène Sichez [France] ; Marianne Serveaux [France] ; Flora Brunner [France] ; Stanislas Bataille [France] | Hydroxychloroquine and azithromycin tolerance in haemodialysis patients during COVID-19 infection. |
| 001061 (2020) |
Daolin Tang [République populaire de Chine, États-Unis] ; Jingbo Li [États-Unis] ; Ruoxi Zhang [États-Unis] ; Rui Kang [États-Unis] ; Daniel J. Klionsky [États-Unis] | Chloroquine in fighting COVID-19: good, bad, or both? |
| 001222 (2020) |
David Lebeaux [France] ; Matthieu Revest [France] | No evidence of clinical benefits of early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: Comment on "Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, France". |
| 001262 (2020) |
François Bénézit ; Audrey Le Bot ; Stéphane Jouneau ; Florian Lemaître ; Charlotte Pronier ; Pierre-Axel Lentz ; Solène Patrat-Delon ; Matthieu Revest ; Vincent Thibault ; Pierre Tattevin | COVID-19 in Patient with Sarcoidosis Receiving Long-Term Hydroxychloroquine Treatment, France, 2020. |
| 001288 (2020) |
Jean-Christophe Lagier [France] ; Matthieu Million [France] ; Philippe Gautret [France] ; Philippe Colson [France] ; Sébastien Cortaredona [France] ; Audrey Giraud-Gatineau [France] ; Stéphane Honoré [France] ; Jean-Yves Gaubert [France] ; Pierre-Edouard Fournier [France] ; Hervé Tissot-Dupont [France] ; Eric Chabrière [France] ; Andreas Stein [France] ; Jean-Claude Deharo [France] ; Florence Fenollar [France] ; Jean-Marc Rolain [France] ; Yolande Obadia [France] ; Alexis Jacquier [France] ; Bernard La Scola [France] ; Philippe Brouqui [France] ; Michel Drancourt [France] ; Philippe Parola [France] ; Didier Raoult [France] | Outcomes of 3,737 COVID-19 patients treated with hydroxychloroquine/azithromycin and other regimens in Marseille, France: A retrospective analysis. |
| 001406 (2020) |
Lucie Pothen [Belgique] ; Halil Yildiz [Belgique] ; Julien De Greef [Belgique] ; Andrea Penaloza [Belgique] ; Christophe Beauloye [Belgique] ; Leila Belkhir [Belgique] ; Jean Cyr Yombi [Belgique] | Safe use of hydroxychloroquine and its combination with azithromycin in the context of Sars-CoV-2 outbreak: Clinical experience in a Belgian tertiary center. |
| 001455 (2020) |
François Danion [France] ; Yvon Ruch [France] ; Marion Fourtage [France] ; Charlotte Kaeuffer [France] ; Valentin Greigert [France] ; Nicolas Lefebvre [France] ; Joris Muller [France] ; Thierry Nai [France] ; Yves Hansmann [France] | The Good, the Bad, and the Hoax: When Publication Instantaneously Impacts Treatment Strategies for COVID-19. |
| 001526 (2020) |
Corneliu P. Popescu [Roumanie] ; Philip R. Fischer [États-Unis] | Hydroxychloroquine-azithromycin for COVID-19 - Warranted or dangerous? |
| 001542 (2020) |
Alice Fanin [Italie] ; Jessica Calegari [Italie] ; Anna Beverina [Italie] ; Silvia Tiraboschi [Italie] | Hydroxychloroquine and azithromycin as a treatment of COVID-19. |
| 001672 (2020) |
Alexandre Gérard [France] ; Serena Romani [France] ; Audrey Fresse [France] ; Delphine Viard [France] ; Nadège Parassol [France] ; Aurélie Granvuillemin [France] ; Laurent Chouchana [France] ; Fanny Rocher [France] ; Milou-Daniel Drici [France] | "Off-label" use of hydroxychloroquine, azithromycin, lopinavir-ritonavir and chloroquine in COVID-19: A survey of cardiac adverse drug reactions by the French Network of Pharmacovigilance Centers. |
